Literature DB >> 7947464

Demonstration of the target molecule of a protective IgE antibody in secretory glands of Schistosoma japonicum larvae.

T Nara1, N Matsumoto, T Janecharut, H Matsuda, K Yamamoto, T Irimura, K Nakamura, M Aikawa, I Oswald, A Sher.   

Abstract

We have demonstrated that a mouse monoclonal IgE antibody, SJ18 epsilon.1, recognizes a 97 kDa surface molecule (Sj97) of Schistosoma japonicum larvae and that the antibody induces partial but significant protection against the skin to lung-stage of S. japonicum infection. The antibody stimulates eosinophil- and macrophage-mediated killing of schistosomula in vitro. In the present study, we isolated the putative full-length cDNA of Sj97 by screening a lambda gt11 cDNA library from S. japonicum adult worms with SJ18 epsilon.1. The predicted amino acid sequence of the cDNA showed highly significant homology to that of S. mansoni paramyosin, a potential vaccine candidate for schistosomiasis. The deletion mutants of S. japonicum paramyosin were expressed in Escherichia coli and the translation product of 443 amino acid residues of paramyosin was found to be recognized by the antibody. Moreover, we observed by immunoelectron microscopy the presence of paramyosin in the post-acetabular gland as well as in the tegument and muscle layers of the larvae. These results suggest that paramyosin is a secretory protein which may be incorporated into the tegument during the development of schistosomula, thus becoming a target for protective immunity during the migratory phase of the parasite.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947464     DOI: 10.1093/intimm/6.7.963

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice.

Authors:  M Fraize; M E Sarciron; S Azzouz; N Issaadi; G Bosquet; A F Petavy
Journal:  Parasitol Res       Date:  2005-04-12       Impact factor: 2.289

2.  Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis.

Authors:  J Vázquez-Talavera; C F Solís; L I Terrazas; J P Laclette
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Receptor for Fc on the surfaces of schistosomes.

Authors:  A Loukas; M K Jones; L T King; P J Brindley; D P McManus
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Molecular cloning and characterization of a paramyosin from Clonorchis sinensis.

Authors:  Tae-Joon Park; Jung-Mi Kang; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

5.  Immune response induced by candidate Sarcoptes scabiei var. cuniculi DNA vaccine encoding paramyosin in mice.

Authors:  Xiaobin Gu; Yue Xie; Shuxian Wang; Xuerong Peng; Songjia Lai; Guangyou Yang
Journal:  Exp Appl Acarol       Date:  2014-04-13       Impact factor: 2.132

Review 6.  Reassessing therapeutic antibodies for neglected and tropical diseases.

Authors:  Rob Hooft van Huijsduijnen; Somei Kojima; Dee Carter; Hisafumi Okabe; Akihide Sato; Wataru Akahata; Timothy N C Wells; Kei Katsuno
Journal:  PLoS Negl Trop Dis       Date:  2020-01-30

7.  An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.

Authors:  Anne-Francoise Petavy; Carlos Hormaeche; Samia Lahmar; Hammou Ouhelli; Alejandro Chabalgoity; Thierry Marchal; Samira Azzouz; Fernanda Schreiber; Gabriela Alvite; Marie-Elisabeth Sarciron; Duncan Maskell; Adriana Esteves; Georges Bosquet
Journal:  PLoS Negl Trop Dis       Date:  2008-01-16

Review 8.  Development of Paramyosin as a Vaccine Candidate for Schistosomiasis.

Authors:  Mario A Jiz; Haiwei Wu; Remigio Olveda; Blanca Jarilla; Jonathan D Kurtis
Journal:  Front Immunol       Date:  2015-07-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.